Surgical Glue Market by Type (Fibrin Sealant, Cyanoacrylate, Collagen-Based Compound, Glutaraldehyde Glue, Hydrogel), by Application (Cardiac Surgery, Pulmonary Surgery, Vascular Surgery, Liver and Spleen Lacerations, Orthopedic Surgery, Burn Bleeding, Plastic Surgery, Wound Management, Neurosurgery, General Surgery), by End User (Hospitals, Clinics), by Geography (U.S., Canada, Germany, France, U.K., Italy, Spain, Japan, China, India, Brazil, Mexico, Saudi Arabia, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Type

1.3.2 Market Segmentation by Application

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

3.1 Voice of Industry Experts/KOLs

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Type

4.1.1.1 Fibrin sealant

4.1.1.2 Cyanoacrylate

4.1.1.3 Collagen-based compound

4.1.1.4 Glutaraldehyde glue

4.1.1.5 Hydrogel

4.1.1.6 Others

4.1.2 By Application

4.1.2.1 Cardiac surgery

4.1.2.2 Pulmonary surgery

4.1.2.3 Vascular surgery

4.1.2.4 Liver and spleen lacerations

4.1.2.5 Orthopedic surgery

4.1.2.6 Burn bleeding

4.1.2.7 Plastic surgery

4.1.2.8 Wound management

4.1.2.9 Neurosurgery

4.1.2.10 General surgery

4.1.2.11 Others

4.1.3 By End User

4.1.3.1 Hospitals

4.1.3.2 Clinics

4.1.3.3 Others

4.2 Value Chain Analysis

4.3 Market Dynamics

4.3.1 Trends

4.3.1.1 Growing popularity of plastic surgeries

4.3.1.2 Expansion in licensed indications for surgical glue

4.3.1.3 Inclination of people toward painless healing procedures

4.3.2 Drivers

4.3.2.1 Rising healthcare expenditure

4.3.2.2 Surging number of surgical procedures and burn cases

4.3.2.3 Growing geriatric population

4.3.2.4 Increasing incidence of road accidents

4.3.2.5 Impact analysis of drivers on market forecast

4.3.3 Restraints

4.3.3.1 Increasing minimally invasive procedures

4.3.3.2 Complications and stringent regulatory requirements

4.3.3.3 Impact analysis of restraints on market forecast

4.3.4 Opportunities

4.3.4.1 Improving healthcare in developed and emerging economies

Chapter 5. Global Market Size and Forecast

5.1 By Type

5.2 By Application

5.3 By End User

5.4 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Type

6.2 By Application

6.3 By End User

6.4 By Country

Chapter 7. Europe Market Size and Forecast

7.1 By Type

7.2 By Application

7.3 By End User

7.4 By Country

Chapter 8. APAC Market Size and Forecast

8.1 By Type

8.2 By Application

8.3 By End User

8.4 By Country

Chapter 9. LATAM Market Size and Forecast

9.1 By Type

9.2 By Application

9.3 By End User

9.4 By Country

Chapter 10. MEA Market Size and Forecast

10.1 By Type

10.2 By Application

10.3 By End User

10.4 By Country

Chapter 11. Competitive Landscape

11.1 Benchmarking of Key Players

11.2 Benchmarking of Key Players, Based on Offerings

11.3 Market Share Analysis of Key Players

11.4 Global Strategic Developments by Key Players

11.4.1 Mergers and Acquisitions

11.4.2 Partnerships

11.4.3 Product Launches

11.4.4 Other Developments

Chapter 12. Company Profiles

12.1 Advanced Medical Solutions Group PLC

12.1.1 Business Overview

12.1.2 Product and Service Offerings

12.1.3 Key Financial Summary

12.1.4 Strategic Growth Plans

12.2 B. Braun Melsungen AG

12.2.1 Business Overview

12.2.2 Product and Service Offerings

12.2.3 Key Financial Summary

12.2.4 Strategic Growth Plans

12.3 Baxter International Inc.

12.3.1 Business Overview

12.3.2 Product and Service Offerings

12.3.3 Key Financial Summary

12.3.4 Strategic Growth Plans

12.4 C. R. Bard Inc.

12.4.1 Business Overview

12.4.2 Product and Service Offerings

12.4.3 Key Financial Summary

12.4.4 Strategic Growth Plans

12.5 Cardinal Health Inc. Inc.

12.5.1 Business Overview

12.5.2 Product and Service Offerings

12.5.3 Key Financial Summary

12.5.4 Strategic Growth Plans

12.6 Cohera Medical Inc.

12.6.1 Business Overview

12.6.2 Product and Service Offerings

12.6.3 Strategic Growth Plans

12.7 CryoLife Inc.

12.7.1 Business Overview

12.7.2 Product and Service Offerings

12.7.3 Key Financial Summary

12.7.4 Strategic Growth Plans

12.8 Integra LifeSciences Holdings Corporation

12.8.1 Business Overview

12.8.2 Product and Service Offerings

12.8.3 Key Financial Summary

12.8.4 Strategic Growth Plans

12.9 Johnson & Johnson

12.9.1 Business Overview

12.9.2 Product and Service Offerings

12.9.3 Key Financial Summary

12.9.4 Strategic Growth Plans

12.10 Medtronic PLC

12.10.1 Business Overview

12.10.2 Product and Service Offerings

12.10.3 Key Financial Summary

12.10.4 Strategic Growth Plans

12.11 Takeda Pharmaceutical Company Limited

12.11.1 Business Overview

12.11.2 Product and Service Offerings

12.11.3 Key Financial Summary

12.11.4 Strategic Growth Plans

Chapter 13. Appendix

13.1 Abbreviations

13.2 Sources and References

 

List of Tables

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 HEALTHCARE EXPENDITURE, USD PER CAPITA (2013 AND 2016)

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5 TOTAL HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP

TABLE 6 GLOBAL SURGICAL GLUE MARKET, BY TYPE, $M (2019–2024)

TABLE 7 GLOBAL SURGICAL GLUE MARKET, BY TYPE, $M (2025–2030)

TABLE 8 GLOBAL SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2024)

TABLE 9 GLOBAL SURGICAL GLUE MARKET, BY APPLICATION, $M (2025–2030)

TABLE 10 GLOBAL SURGICAL GLUE MARKET, BY END USER, $M (2019–2024)

TABLE 11 GLOBAL SURGICAL GLUE MARKET, BY END USER, $M (2025–2030)

TABLE 12 GLOBAL SURGICAL GLUE MARKET, BY REGION, $M (2019–2024)

TABLE 13 GLOBAL SURGICAL GLUE MARKET, BY REGION, $M (2025–2030)

TABLE 14 NORTH AMERICA SURGICAL GLUE MARKET, BY TYPE, $M (2019–2024)

TABLE 15 NORTH AMERICA SURGICAL GLUE MARKET, BY TYPE, $M (2025–2030)

TABLE 16 NORTH AMERICA SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2024)

TABLE 17 NORTH AMERICA SURGICAL GLUE MARKET, BY APPLICATION, $M (2025–2030)

TABLE 18 NORTH AMERICA SURGICAL GLUE MARKET, BY END USER, $M (2019–2024)

TABLE 19 NORTH AMERICA SURGICAL GLUE MARKET, BY END USER, $M (2025–2030)

TABLE 20 NORTH AMERICA SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2024)

TABLE 21 NORTH AMERICA SURGICAL GLUE MARKET, BY COUNTRY, $M (2025–2030)

TABLE 22 EUROPE SURGICAL GLUE MARKET, BY TYPE, $M (2019–2024)

TABLE 23 EUROPE SURGICAL GLUE MARKET, BY TYPE, $M (2025–2030)

TABLE 24 EUROPE SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2024)

TABLE 25 EUROPE SURGICAL GLUE MARKET, BY APPLICATION, $M (2025–2030)

TABLE 26 EUROPE SURGICAL GLUE MARKET, BY END USER, $M (2019–2024)

TABLE 27 EUROPE SURGICAL GLUE MARKET, BY END USER, $M (2025–2030)

TABLE 28 EUROPE SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2024)

TABLE 29 EUROPE SURGICAL GLUE MARKET, BY COUNTRY, $M (2025–2030)

TABLE 30 GDP PER CAPITA OF COUNTRIES, IN USD (2015 AND 2016)

TABLE 31 APAC SURGICAL GLUE MARKET, BY TYPE, $M (2019–2024)

TABLE 32 APAC SURGICAL GLUE MARKET, BY TYPE, $M (2025–2030)

TABLE 33 APAC SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2024)

TABLE 34 APAC SURGICAL GLUE MARKET, BY APPLICATION, $M (2025–2030)

TABLE 35 APAC SURGICAL GLUE MARKET, BY END USER, $M (2019–2024)

TABLE 36 APAC SURGICAL GLUE MARKET, BY END USER, $M (2025–2030)

TABLE 37 APAC SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2024)

TABLE 38 APAC SURGICAL GLUE MARKET, BY COUNTRY, $M (2025–2030)

TABLE 39 COST OF MEDICAL TREATMENT IN BRAZIL AND U.S. HOSPITALS

TABLE 40 LATAM SURGICAL GLUE MARKET, BY TYPE, $M (2019–2024)

TABLE 41 LATAM SURGICAL GLUE MARKET, BY TYPE, $M (2025–2030)

TABLE 42 LATAM SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2024)

TABLE 43 LATAM SURGICAL GLUE MARKET, BY APPLICATION, $M (2025–2030)

TABLE 44 LATAM SURGICAL GLUE MARKET, BY END USER, $M (2019–2024)

TABLE 45 LATAM SURGICAL GLUE MARKET, BY END USER, $M (2025–2030)

TABLE 46 LATAM SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2024)

TABLE 47 LATAM SURGICAL GLUE MARKET, BY COUNTRY, $M (2025–2030)

TABLE 48 MEA SURGICAL GLUE MARKET, BY TYPE, $M (2019–2024)

TABLE 49 MEA SURGICAL GLUE MARKET, BY TYPE, $M (2025–2030)

TABLE 50 MEA SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2024)

TABLE 51 MEA SURGICAL GLUE MARKET, BY APPLICATION, $M (2025–2030)

TABLE 52 MEA SURGICAL GLUE MARKET, BY END USER, $M (2019–2024)

TABLE 53 MEA SURGICAL GLUE MARKET, BY END USER, $M (2025–2030)

TABLE 54 MEA SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2024)

TABLE 55 MEA SURGICAL GLUE MARKET, BY COUNTRY, $M (2025–2030)

TABLE 56 BENCHMARKING OF KEY PLAYERS

TABLE 57 ADVANCED MEDICAL SOLUTIONS GROUP PLC – AT A GLANCE

TABLE 58 ADVANCED MEDICAL SOLUTIONS GROUP PLC – KEY FINANCIAL SUMMARY

TABLE 59 B. BRAUN MELSUNGEN AG – AT A GLANCE

TABLE 60 B. BRAUN MELSUNGEN AG - KEY FINANCIAL SUMMARY

TABLE 61 BAXTER INTERNATIONAL INC. – AT A GLANCE

TABLE 62 BAXTER INTERNATIONAL INC. - KEY FINANCIAL SUMMARY

TABLE 63 C. R. BARD INC. – AT A GLANCE

TABLE 64 C. R. BARD INC. - KEY FINANCIAL SUMMARY

TABLE 65 CARDINAL HEALTH INC. – AT A GLANCE

TABLE 66 CARDINAL HEALTH INC. - KEY FINANCIAL SUMMARY

TABLE 67 COHERA MEDICAL INC. – AT A GLANCE

TABLE 68 CRYOLIFE INC. – AT A GLANCE

TABLE 69 CRYOLIFE INC. - KEY FINANCIAL SUMMARY

TABLE 70 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – AT A GLANCE

TABLE 71 INTEGRA LIFESCIENCES HOLDINGS CORPORATION - KEY FINANCIAL SUMMARY

TABLE 72 JOHNSON & JOHNSON - AT A GLANCE

TABLE 73 MEDTRONIC PLC – AT A GLANCE

TABLE 74 MEDTRONIC PLC – KEY FINANCIAL SUMMARY

TABLE 75 TAKEDA PHARMACEUTICAL COMPANY LIMITED – AT A GLANCE

TABLE 76 TAKEDA PHARMACEUTICAL COMPANY LIMITED - KEY FINANCIAL SUMMARY

 

List of Figures

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY FOR GLOBAL SURGICAL GLUE MARKET

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL SURGICAL GLUE MARKET SUMMARY

FIG 9 VALUE CHAIN ANALYSIS

FIG 10 AESTHETIC/COSMETIC PROCEDURES PERFORMED GLOBALLY (2015 AND 2016)

FIG 11 PROJECTED GLOBAL GERIATRIC POPULATION (60 YEARS OR ABOVE)

FIG 12 GERIATRIC POPULATION AS PERCENTAGE OF TOTAL POPULATION

FIG 13 WORLDWIDE ROAD TRAFFIC DEATHS

FIG 14 ROAD TRAFFIC FATALITY RATE PER HUNDRED THOUSAND PEOPLE

FIG 15 GLOBAL SURGICAL GLUE MARKET, BY TYPE, $M (2019–2030)

FIG 16 GLOBAL SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2030)

FIG 17 GLOBAL SURGICAL GLUE MARKET, BY END USER, $M (2019–2030)

FIG 18 WORLDWIDE MAJOR MARKETS FOR SURGICAL GLUE

FIG 19 GLOBAL SURGICAL GLUE MARKET, BY REGION, $M (2019–2030)

FIG 20 NORTH AMERICA SURGICAL GLUE MARKET SNAPSHOT

FIG 21 NORTH AMERICA SURGICAL GLUE MARKET, BY TYPE, $M (2019–2030)

FIG 22 NORTH AMERICA SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2030)

FIG 23 NORTH AMERICA SURGICAL GLUE MARKET, BY END USER, $M (2019–2030)

FIG 24 NORTH AMERICA SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2030)

FIG 25 EUROPE SURGICAL GLUE MARKET SNAPSHOT

FIG 26 EUROPE SURGICAL GLUE MARKET, BY TYPE, $M (2019–2030)

FIG 27 EUROPE SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2030)

FIG 28 EUROPE SURGICAL GLUE MARKET, BY END USER, $M (2019–2030)

FIG 29 EUROPE SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2030)

FIG 30 APAC SURGICAL GLUE MARKET SNAPSHOT

FIG 31 APAC SURGICAL GLUE MARKET, BY TYPE, $M (2019–2030)

FIG 32 APAC SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2030)

FIG 33 APAC SURGICAL GLUE MARKET, BY END USER, $M (2019–2030)

FIG 34 APAC SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2030)

FIG 35 LATAM SURGICAL GLUE MARKET SNAPSHOT

FIG 36 LATAM SURGICAL GLUE MARKET, BY TYPE, $M (2019–2030)

FIG 37 LATAM SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2030)

FIG 38 LATAM SURGICAL GLUE MARKET, BY END USER, $M (2019–2030)

FIG 39 LATAM SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2030)

FIG 40 MEA SURGICAL GLUE MARKET SNAPSHOT

FIG 41 MEA SURGICAL GLUE MARKET, BY TYPE, $M (2019–2030)

FIG 42 MEA SURGICAL GLUE MARKET, BY APPLICATION, $M (2019–2030)

FIG 43 MEA SURGICAL GLUE MARKET, BY END USER, $M (2019–2030)

FIG 44 MEA SURGICAL GLUE MARKET, BY COUNTRY, $M (2019–2030)

FIG 45 BENCHMARKING OF KEY PLAYERS IN SURGICAL GLUE MARKET, BY TYPE, 2017

FIG 46 GLOBAL SURGICAL GLUE MARKET SHARE, BY COMPANY (2016)

FIG 47 STRATEGIC DEVELOPMENTS OF KEY PLAYERS (2016 AND 2017)

FIG 48 ADVANCED MEDICAL SOLUTIONS GROUP PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2016)

FIG 49 B. BRAUN MELSUNGEN AG - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2016)

FIG 50 BAXTER INTERNATIONAL INC. - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2016)

FIG 51 C. R. BARD INC. - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2016)

FIG 52 CARDINAL HEALTH INC. - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2023)

FIG 53 CRYOLIFE INC. - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2016)

FIG 54 INTEGRA LIFESCIENCES HOLDINGS CORPORATION - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2016)

FIG 55 JOHNSON & JOHNSON REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2016)

FIG 56 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 57 TAKEDA PHARMACEUTICAL COMPANY LIMITED - REVENUE SPLIT BY GEOGRAPHY (2016)